Can AI in Health Be Shaped by Policy Before the Market Runs Ahead?
CEPS takes a policy-level view of AI in health, asking how regulation and governance can shape the technology’s future rather than merely react to it. The piece is notable for framing AI as a system-level policy challenge, not just a clinical innovation.
Policy debates around healthcare AI are moving from abstract ethics to practical governance. This article matters because it treats AI as a structural issue — one that affects competition, access, safety, and institutional accountability at the same time.
That broader lens is overdue. Health systems are already making decisions about procurement, data sharing, liability, and oversight, and those choices will determine whether AI deepens fragmentation or becomes a standard part of care delivery. Governments and regulators therefore have a window of opportunity to shape incentives before the market hardens around a few dominant players.
The challenge is balance. Too little oversight can produce unsafe or opaque systems, but overly rigid rules can discourage useful deployment or push companies to exit certain markets. The best policy approach will likely focus on performance, transparency, and ongoing monitoring rather than one-time approval.
The piece is significant because it reflects the next phase of healthcare AI governance: not whether the technology should exist, but how to make its adoption legible, accountable, and equitable. That is where the real political work now sits.